Attached files
| file | filename |
|---|---|
| EX-5.1 - EXHIBIT 5.1 - Panbela Therapeutics, Inc. | ex_201822.htm |
| EX-1.1 - EXHIBIT 1.1 - Panbela Therapeutics, Inc. | ex_201831.htm |
| S-1/A - FORM S-1/A - Panbela Therapeutics, Inc. | snbp20200826_s1a.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the reference to our firm under the caption “Experts” in this Registration Statement on Form S-1 and related prospectus of Sun BioPharma, Inc. and to the inclusion therein of our report, dated March 24, 2020, with respect to the consolidated financial statements of Sun BioPharma, Inc. appearing in its Form 10-K filed March 24, 2020 with the Securities and Exchange Commission.
/s/ Cherry Bekaert LLP
Tampa, Florida
August 27, 2020